£10m medicine centre aims to develop 'groundbreaking' cancer treatments
A new £10 million centre for excellence in precision medicine has been launched at Queen's University Belfast.
The centre will be working on developing a laboratory to focus on diagnostics which can be used to predict cancer patients' response to treatment. It is hoped that this could allow potentially costly drugs to be used more effectively by being prescribed only to those who can benefit from them.
The unit will be based in the Centre of Cancer Research and Cell Biology at Queen's University and employ 17 members of staff.
The project has been part financed by Invest NI, which has pledged £5.8m towards its cost.
Making the announcement, Invest NI's chief executive, Alastair Hamilton said: "This new precision medicine centre has the potential to develop groundbreaking treatments for cancer patients and will further enhance the personalised medicine and oncology research sector in Northern Ireland.
"While initially research will focus on cancer, this could extend into other areas of precision medicine in the future."